CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).